Literature DB >> 20378837

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.

Wenwei Hu1, Cen Zhang, Rui Wu, Yvonne Sun, Arnold Levine, Zhaohui Feng.   

Abstract

Whereas cell cycle arrest, apoptosis, and senescence are traditionally thought of as the major functions of the tumor suppressor p53, recent studies revealed two unique functions for this protein: p53 regulates cellular energy metabolism and antioxidant defense mechanisms. Here, we identify glutaminase 2 (GLS2) as a previously uncharacterized p53 target gene to mediate these two functions of the p53 protein. GLS2 encodes a mitochondrial glutaminase catalyzing the hydrolysis of glutamine to glutamate. p53 increases the GLS2 expression under both nonstressed and stressed conditions. GLS2 regulates cellular energy metabolism by increasing production of glutamate and alpha-ketoglutarate, which in turn results in enhanced mitochondrial respiration and ATP generation. Furthermore, GLS2 regulates antioxidant defense function in cells by increasing reduced glutathione (GSH) levels and decreasing ROS levels, which in turn protects cells from oxidative stress (e.g., H(2)O(2))-induced apoptosis. Consistent with these functions of GLS2, the activation of p53 increases the levels of glutamate and alpha-ketoglutarate, mitochondrial respiration rate, and GSH levels and decreases reactive oxygen species (ROS) levels in cells. Furthermore, GLS2 expression is lost or greatly decreased in hepatocellular carcinomas and the overexpression of GLS2 greatly reduced tumor cell colony formation. These results demonstrated that as a unique p53 target gene, GLS2 is a mediator of p53's role in energy metabolism and antioxidant defense, which can contribute to its role in tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378837      PMCID: PMC2867677          DOI: 10.1073/pnas.1001006107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The p53MH algorithm and its application in detecting p53-responsive genes.

Authors:  J Hoh; S Jin; T Parrado; J Edington; A J Levine; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

3.  The coordinate regulation of the p53 and mTOR pathways in cells.

Authors:  Zhaohui Feng; Haiyan Zhang; Arnold J Levine; Shengkan Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

4.  Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.

Authors:  Wenwei Hu; Zhaohui Feng; Moon-shong Tang
Journal:  Biochemistry       Date:  2004-11-09       Impact factor: 3.162

5.  Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD.

Authors:  Andrei V Budanov; Anna A Sablina; Elena Feinstein; Eugene V Koonin; Peter M Chumakov
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

6.  Transcriptional activation of the human glutathione peroxidase promoter by p53.

Authors:  M Tan; S Li; M Swaroop; K Guan; L W Oberley; Y Sun
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

7.  Genomic organization and transcriptional analysis of the human l-glutaminase gene.

Authors:  Cristina Pérez-Gómez; José M Matés; Pedro M Gómez-Fabre; Antonio del Castillo-Olivares; Francisco J Alonso; Javier Márquez
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

8.  Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

Authors:  Michele Albertoni; Phillip H Shaw; Michimasa Nozaki; Sophie Godard; Mirna Tenan; Marie-France Hamou; Douglas W Fairlie; Samuel N Breit; Vishwas M Paralkar; Nicolas de Tribolet; Erwin G Van Meir; Monika E Hegi
Journal:  Oncogene       Date:  2002-06-20       Impact factor: 9.867

9.  Transfection with liver-type glutaminase cDNA alters gene expression and reduces survival, migration and proliferation of T98G glioma cells.

Authors:  Monika Szeliga; Marta Obara-Michlewska; Ewa Matyja; Marzena Łazarczyk; Carolina Lobo; Wojciech Hilgier; Francisco J Alonso; Javier Márquez; Jan Albrecht
Journal:  Glia       Date:  2009-07       Impact factor: 7.452

10.  Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.

Authors:  Kyong-Ah Yoon; Yusuke Nakamura; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2004-02-25       Impact factor: 3.172

View more
  357 in total

1.  Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect.

Authors:  Cen Zhang; Meihua Lin; Rui Wu; Xiaowen Wang; Bo Yang; Arnold J Levine; Wenwei Hu; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 2.  p53 and metabolism: old player in a new game.

Authors:  Nirmalya Sen; Yatendra Kumar Satija; Sanjeev Das
Journal:  Transcription       Date:  2012 May-Jun

3.  Journal club. A cancer biologist weighs up p53, metabolism and cancer.

Authors:  Gerry Melino
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

4.  Alternative fuel--another role for p53 in the regulation of metabolism.

Authors:  Karen H Vousden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-14       Impact factor: 11.205

Review 5.  The engine driving the ship: metabolic steering of cell proliferation and death.

Authors:  Marisa R Buchakjian; Sally Kornbluth
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

Review 6.  Alterations of metabolic genes and metabolites in cancer.

Authors:  Eric K Oermann; Jing Wu; Kun-Liang Guan; Yue Xiong
Journal:  Semin Cell Dev Biol       Date:  2012-01-28       Impact factor: 7.727

Review 7.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

Review 8.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

9.  Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.

Authors:  Yang Ou; Shang-Jui Wang; Dawei Li; Bo Chu; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

10.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Authors:  Yan Xiang; Zachary E Stine; Jinsong Xia; Yunqi Lu; Roddy S O'Connor; Brian J Altman; Annie L Hsieh; Arvin M Gouw; Ajit G Thomas; Ping Gao; Linchong Sun; Libing Song; Benedict Yan; Barbara S Slusher; Jingli Zhuo; London L Ooi; Caroline G L Lee; Anthony Mancuso; Andrew S McCallion; Anne Le; Michael C Milone; Stephen Rayport; Dean W Felsher; Chi V Dang
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.